Lebrikizumab After Multiple Prior Advanced Therapies in Moderate‐To‐Severe Atopic Dermatitis: A Real‐World Case Series

The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.